A 41-year-old man developed subacute neurotoxicity associated with
interleukin-2 and tumor necrosis factor therapy for metastatic renal cell
carcinoma. Cognitive deficits revealed on neuropsychological testing and
frontal lobe perfusion deficits revealed on SPECT resolved after 1 month.
Findings suggest possible neuroanatomic and physiologic substrates of
cytokine neurotoxicity.Abstract Teaser